- Full Year 2023 Wolters Kluwer NV Earnings Call TranscriptFeb 21, 2024$157.22 (-1.13%)Earnings
- Wolters Kluwer Virtual Teach-In: Financial & Corporate Compliance & DXG TranscriptNov 30, 2023
- Half Year 2023 Wolters Kluwer NV Earnings Call TranscriptAug 02, 2023$122.29 (-2.03%)Earnings
- Wolters Kluwer NV Annual Shareholders Meeting TranscriptMay 10, 2023
- Full Year 2022 Wolters Kluwer NV Earnings Call TranscriptFeb 22, 2023$116.64 (+5.28%)Earnings
- Wolters Kluwer NV Virtual Teach-In: Tax and Accounting Presentation TranscriptDec 06, 2022
- Half Year 2022 Wolters Kluwer NV Earnings Call TranscriptAug 03, 2022$109.28 (+2.14%)Earnings
- Wolters Kluwer NV Annual Shareholders Meeting TranscriptApr 21, 2022
- Full Year 2021 Wolters Kluwer NV Earnings Call TranscriptFeb 23, 2022$99.79 (+1.88%)Earnings
- Wolters Kluwer NV Virtual Teach-In: Health & Technology TranscriptDec 09, 2021
- Karnov Group AB (publ) Announces Binding Offer to Acquire Thomson Reuters Spain and Wolters Kluwer in Spain and France TranscriptDec 09, 2021
- Half Year 2021 Wolters Kluwer NV Earnings Call TranscriptAug 04, 2021$114.2 (+0.58%)Earnings
- Wolters Kluwer NV Annual Shareholders Meeting TranscriptApr 22, 2021
- Full Year 2020 Wolters Kluwer NV Earnings Call TranscriptFeb 24, 2021$77.68 (-6.21%)Earnings
- Half Year 2020 Wolters Kluwer NV Earnings Call TranscriptAug 05, 2020$82.79 (+3.64%)Earnings
- Wolters Kluwer NV Annual Shareholders Meeting TranscriptApr 23, 2020
- Full Year 2019 Wolters Kluwer NV Earnings Call TranscriptFeb 26, 2020$75.18 (+3.57%)Earnings
- Half Year 2019 Wolters Kluwer NV Earnings Call TranscriptJul 31, 2019$72.37 (-0.85%)Earnings
- Full Year 2018 Wolters Kluwer NV Earnings Call TranscriptFeb 20, 2019$64.2 (+2.46%)Earnings
Wolters Kluwer NV Virtual Teach-In: Health & Technology Transcript
Good morning, and good afternoon, everyone, on this call. Welcome to Wolters Kluwer Teach-In: Health & Technology. I'm Meg Geldens, Head of Investor Relations at Wolters Kluwer, and I'll be moderating today's call. The IR team at Wolters Kluwer is delighted to be able to host this teach-in today. Our intention is to stage more of these short virtual events next year. The agenda for today is to set some context and then provide a deep dive into 2 of our largest products in Health, UpToDate and Ovid. And for the first time ever, I believe, we will be shining the spotlight on our central product development group, */dxg, and how they are supporting the health division.
Before I introduce the speakers today, just a word on the plan for asking questions. Following the presentations, there will be a chance for you to ask questions. (Operator Instructions) Before we begin, I would like to ask you to read Slide 2 regarding forward-looking statements that we may make. Wolters Kluwer cautions as always, that such forward-looking statements are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)